Evaluation of inhalation of budesonide bitween suspension and aerosol in the treatment of infant asthma
- VernacularTitle:吸入布地奈德混悬液与气雾剂治疗婴幼儿哮喘的疗效评价
- Author:
Jinghong YU
;
Shaofeng YANG
;
Zhiqin LIAO
- Publication Type:Journal Article
- Keywords:
Asthma;
Budesonide;
Infant
- From:
Chinese Journal of Primary Medicine and Pharmacy
2008;15(6):983-985
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy of inhalation of budesonide bitween suspension and aerosol in the treatment of infant asthma. Methods 80 patients less than 3 years old were divided in three groups randomly,in group A the patients received budesonide suspension inhalation therapy,in group B the patients received budesonide aeroso inhalation therapy, in group C the patients received route treament. The patients were followed 1,3,6,12 months after teeament,symptom assessment scores, acute episode of asthma and administration of medication were compared beteen two groups. Results Compared with group C, symptom assessment scores became lower (P <0.01 ) ,acute episode of asthma reduced and use of receptor β2 receptor agonist and steroid reduced in group A and B(P<0.01);after 1,3,6 montha, the indicators observed in group A was better than in group B(P< 0.05),but there was no difference between two group after 12 months( P > 0.05). Conclusion Budesonide inhalaton is effec-tire in the treatment of asthma, in patients with infant asthma, budesonide suspension aerosol inhalation should be the first choice of treatment.
